[HTML] springer.comFull View

[HTML][HTML] Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

S Ajeganova, MLE Andersson, J Frostegård… - Arthritis Research & …, 2021 - Springer
Background The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …
被引用次数：3 相关文章
[HTML] biomedcentral.com

[HTML][HTML] Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

S Ajeganova, MLE Andersson… - Arthritis …, 2021 - arthritis-research.biomedcentral.com
The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA) is not fully
explained by traditional risk factors. Immuno-inflammatory mechanisms and autoantibodies …

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

S Ajeganova, MLE Andersson, J Frostegård… - Arthritis Research and …, 2021 - lup.lub.lu.se
Background: The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …
[PDF] archive.org

[PDF][PDF] Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

S Ajeganova, MLE Andersson, J Frostegård, I Hafström - 2021 - scholar.archive.org
Background: The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

S Ajeganova, MLE Andersson… - Arthritis Research & …, 2021 - researchportal.vub.be
BACKGROUND: The increased risk of cardiovascular events (CVE) in rheumatoid arthritis
(RA) is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.

S Ajeganova, MLE Andersson, J Frostegård… - Arthritis Research & …, 2021 - europepmc.org
Background The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …
[HTML] nih.gov

[HTML][HTML] Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

S Ajeganova, MLE Andersson… - Arthritis Research & …, 2021 - ncbi.nlm.nih.gov
Background The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

S Ajeganova, MLE Andersson… - Arthritis Research & …, 2021 - search.proquest.com
Background The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

S Ajeganova, MLE Andersson… - Arthritis Research …, 2021 - portal.research.lu.se
Background: The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.

S Ajeganova, MLE Andersson, J Frostegård… - Arthritis Research & …, 2021 - go.gale.com
Background The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA)
is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and …